Rate and duration of hospitalization for deep vein thrombosis and pulmonary embolism in real-world clinical practice
- 18 September 2015
- journal article
- research article
- Published by Taylor & Francis in Annals of Medicine
- Vol. 47 (7) , 546-554
Abstract
Current guidelines recommend initial treatment with anticoagulants at home in patients with acute deep vein thrombosis (DVT) and in patients with low-risk pulmonary embolism (PE) with adequate home circumstances. However, most of the patients with acute venous thromboembolism (VTE) are currently hospitalized regardless of their risk of short-term complications. To assess the proportion of outpatients with acute VTE initially treated in hospitals, to assess the mean duration of hospitalization, and to identify predictors for in-hospital or home treatment. Data of Italian patients enrolled in the RIETE registry from January 2006 to December 2013 were included. Altogether 766 PE and 1,452 isolated DVT were included. Among PE patients, mean PESI score was 84 points (SD 35), and 56% of patients had a low-risk PESI score (<85). In all, 53.7% of DVT and 17.0% of PE were entirely treated at home, and 38.2% of DVT patients and 19.9% of PE patients were hospitalized for ≤5 days. On multivariate analysis, low PESI score was not independently associated with the hospitalization of PE patients. One in every two patients with DVT and five in every six with PE are still hospitalized.Keywords
This publication has 17 references indexed in Scilit:
- Management of venous thrombo-embolism: an updateEuropean Heart Journal, 2014
- Trends in hospital admissions for pulmonary embolism in Spain from 2002 to 2011European Respiratory Journal, 2014
- Advantages and limitations of the new anticoagulantsJournal of Internal Medicine, 2013
- Prognostic clinical prediction rules to identify a low‐risk pulmonary embolism: a systematic review and meta‐analysisJournal of Thrombosis and Haemostasis, 2012
- Antithrombotic Therapy for VTE DiseaseChest, 2012
- Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trialThe Lancet, 2011
- Acute Pulmonary EmbolismNew England Journal of Medicine, 2010
- Home treatment in pulmonary embolismThrombosis Research, 2010
- Deep-vein thrombosisThe Lancet, 1999
- Expanding Eligibility for Outpatient Treatment of Deep Venous Thrombosis and Pulmonary Embolism With Low-Molecular-Weight HeparinArchives of internal medicine (1960), 1998